Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Standalone figures · ₹ crore

₹ Cr	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	545	520	504	502	526	523	528	552	568	580	619	756
COGS	354	356	323	336	356	354	346	364	368	382	372	478
Gross profit	192	164	181	166	170	169	182	187	199	198	247	278
	128	120	131	115	129	122	119	125	142	141	155	175
	64	44	50	51	42	47	63	62	57	57	93	104
OPM %	11.8%	8.6%	9.9%	10.1%	7.9%	9%	11.9%	11.3%	10.1%	9.9%	14.9%	13.7%
Depreciation	16	16	16	17	18	19	19	20	20	20	20	21
Interest	4	4	3	2	4	4	4	4	3	4	3	4
	7	8	8	7	6	4	5	7	7	-6	2	8
Profit before tax	51	32	38	39	26	28	45	46	41	28	71	87
Tax	13	9	10	10	7	7	13	12	11	7	18	22
Tax %	26.1%	28%	25.4%	24.3%	26.2%	26.1%	29.6%	25.4%	26%	25.3%	24.9%	25.7%
	38	23	28	30	19	21	32	34	30	21	53	64
PAT margin %	6.9%	4.5%	5.6%	5.9%	3.6%	3.9%	6%	6.2%	5.3%	3.6%	8.6%	8.5%
EPS (₹)	6.4	4	4.8	5.1	3.3	3.5	1.1	1.2	1	0.7	1.8	2.2
Results filing	—	—	—	—	—	—	—	Results filing for Jun 2025	Results filing for Sep 2025	Results filing for Dec 2025	Results filing for Mar 2026	Results filing for Jun 2026

vs same quarter last year	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue YoY %	+0.7%	-0.6%	-14.2%	-10.8%	-3.6%	+0.6%	+4.7%	+9.8%

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 30 Jun 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed
Pharmaceutical	469.49	68.81	1,664.88	283.58	1,381.3
Chemical	364.96	17.32	694.76	330.57	364.19